The risk of nonalcoholic fatty liver disease in gout patients with frequent flares: a retrospective cohort study

被引:4
作者
Si, Ke [1 ]
Chi, Jingwei [1 ]
Xu, Lili [1 ]
Dong, Bingzi [1 ]
Liu, Chuanfeng [1 ]
Chen, Ying [1 ]
Wang, Yangang [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266003, Peoples R China
关键词
Adipo-IR; Frequency of gout flares; Gout; Non-alcoholic fatty liver disease; INSULIN-RESISTANCE; ADIPOSE-TISSUE; URIC-ACID; ARTHRITIS; CRITERIA; ATTACKS;
D O I
10.1007/s10067-023-06510-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease that is related to high serum uric acid; however, the association between the frequency of gout flares and NAFLD risk remains unclear. This study aimed to investigate whether frequent gout flares were associated with incident NAFLD and analyze the interaction of frequency of gout flares and Adipo-IR on NAFLD in the gout Chinese population. Methods A total of 350 cases of gout patients were enrolled in this retrospective cohort study. Cox proportional hazard regression analyses were performed to determine the association between frequent gout flares and NAFLD during follow-up and analyze the interaction of frequency of gout flares and Adipo-IR on NAFLD. Receiver operating curves (ROC) were plotted to explore the diagnostic value of frequent gout flares and Adipo-IR on the occurrence of NAFLD. Results NAFLD developed in 78 participants (22.3%) during follow-up. Logistic regression showed that Adipo-IR was an independent factor associated with frequent gout flares risk. The multivariate Cox regression analysis revealed that frequent gout flares and Adipo-IR were associated with NAFLD risk (HR: 7.88, 95% CI: 2.11-29.48, p < 0.01; HR: 1.058, 95% CI: 1.01-1.2, p < 0.05). And ROC showed that both of them had a great discriminant ability to diagnose NAFLD. Conclusions Our data showed an independent association between the frequency of gout flares or Adipo-IR and incident NAFLD. Frequent gout flares and elevated Adipo-IR had a good predictive capability towards NAFLD development and played a synergistic role in the development of NAFLD.
引用
收藏
页码:1389 / 1395
页数:7
相关论文
共 50 条
  • [21] Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study
    Lin, Xian-Feng
    Shi, Ke-Qing
    You, Jie
    Liu, Wen-Yue
    Luo, Ying-Wan
    Wu, Fa-Ling
    Chen, Yong-Ping
    Wong, Danny Ka-Ho
    Yuen, Man-Fung
    Zheng, Ming-Hua
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (05) : 2989 - 2997
  • [22] Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    Potze, Wilma
    Siddiqui, M. Shadab
    Sanyal, Arun J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (05) : 488 - 493
  • [23] Hyperferritinemia in patients with nonalcoholic fatty liver disease
    Barros, Raffaelle K.
    Cotrim, Helma Pinchemel
    Daltro, Carla H.
    Oliveira, Yanaihara A.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (03): : 284 - 289
  • [24] Metabolic aspects of adult patients with nonalcoholic fatty liver disease
    Abenavoli, Ludovico
    Milic, Natasa
    Di Renzo, Laura
    Preveden, Tomislav
    Medic-Stojanoska, Milica
    De Lorenzo, Antonino
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (31) : 7006 - 7016
  • [25] Osteokines in Nonalcoholic Fatty Liver Disease
    Vachliotis, Ilias D.
    Anastasilakis, Athanasios D.
    Rafailidis, Vasileios
    Polyzos, Stergios A.
    CURRENT OBESITY REPORTS, 2024, 13 (04): : 703 - 723
  • [26] Nonalcoholic Fatty Liver Disease as a Potential Risk Factor for Cardiovascular Disease in Patients with Type 2 Diabetes: A Prospective Cohort Study
    Dehghani Firouzabadi, Mohammad
    Poopak, Amirhossein
    Sheikhy, Ali
    Firouzabadi, Fatemeh Dehghani
    Moosaie, Fatemeh
    Rabizadeh, Soghra
    Momtazmanesh, Sara
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
  • [27] Comparative study of overweight and obese patients with nonalcoholic fatty liver disease
    Aller, Rocio
    Burgueno, Beatriz
    Siguenza, Rebeca
    Fernandez-Rodriguez, Conrado
    Fernandez, Natalia
    Antolin, Beatriz
    Dura, Miguel
    Pina, Maria
    Lorenzo, Sara
    Garcia, Concepcion
    de Luis, Daniel A.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (04) : 256 - 263
  • [28] Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease
    Fujii, Hideki
    Fujii, Makoto
    Iwaki, Michihiro
    Hayashi, Hideki
    Toyoda, Hidenori
    Oeda, Satoshi
    Hyogo, Hideyuki
    Kawanaka, Miwa
    Morishita, Asahiro
    Munekage, Kensuke
    Kawata, Kazuhito
    Tsutsumi, Tsubasa
    Sawada, Koji
    Maeshiro, Tatsuji
    Tobita, Hiroshi
    Yoshida, Yuichi
    Naito, Masafumi
    Araki, Asuka
    Arakaki, Shingo
    Kawaguchi, Takumi
    Noritake, Hidenao
    Ono, Masafumi
    Masaki, Tsutomu
    Yasuda, Satoshi
    Tomita, Eiichi
    Yoneda, Masato
    Kawada, Norifumi
    Tokushige, Akihiro
    Kamada, Yoshihiro
    Takahashi, Hirokazu
    Ueda, Shinichiro
    Aishima, Shinichi
    Sumida, Yoshio
    Nakajima, Atsushi
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2023, 53 (05) : 391 - 400
  • [29] Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study
    Cushman, Mary A.
    Callas, Peter D.
    Alexander, Kristine W.
    Wadley, Virginia E.
    Zakai, Neil D.
    Lidofsky, Steven D.
    Unverzagt, Frederick D.
    Judd, Suzanne D.
    PLOS ONE, 2023, 18 (04):
  • [30] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C. M. A.
    van der Peet, Donald L.
    Bloemena, Elisabeth
    Mulder, Chris J. J.
    PANCREAS, 2010, 39 (08) : 1185 - 1190